Real-World Betaseron Health Economic Outcomes Study for Relapsing Forms of Multiple Sclerosis
Public ClinicalTrials.gov record NCT01158183. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Real-World Betaseron® Outcomes Study (ROBUST): A Twelve-month, US Prospective, Observational, Open-label, Single-arm, Multi-center Outcomes Study of Interferon β-1b (Betaseron®) Given Every Other Day for Relapsing Forms of Multiple Sclerosis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Web based real world observational study in Relapsing-Remitting Multiple Sclerosis (RRMS) population capturing outcomes reported by patients and by the physicians during 12 months after initiating or resuming Betaseron.
Study identification
- NCT ID
- NCT01158183
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 226 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2007 (Type not available)
- Primary completion
- Sep 2009 (Actual)
- Completion
- Sep 2009 (Actual)
- Last update posted
- Jul 8, 2010
2007 – 2009
United States locations
- U.S. sites
- 27
- U.S. states
- 27
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Many Locations | Alabama | — | — |
| Not listed | Many Locations | California | — | — |
| Not listed | Many Locations | Colorado | — | — |
| Not listed | Many Locations | Florida | — | — |
| Not listed | Many Locations | Illinois | — | — |
| Not listed | Many Locations | Iowa | — | — |
| Not listed | Many Locations | Kansas | — | — |
| Not listed | Many Locations | Louisiana | — | — |
| Not listed | Many Locations | Maine | — | — |
| Not listed | Many Locations | Massachusetts | — | — |
| Not listed | Many Locations | Michigan | — | — |
| Not listed | Many Locations | Missouri | — | — |
| Not listed | Many Locations | Nevada | — | — |
| Not listed | Many Locations | New Hampshire | — | — |
| Not listed | Many Locations | New Jersey | — | — |
| Not listed | Many Locations | New York | — | — |
| Not listed | Many Locations | North Carolina | — | — |
| Not listed | Many Locations | North Dakota | — | — |
| Not listed | Many Locations | Ohio | — | — |
| Not listed | Many Locations | Oregon | — | — |
| Not listed | Many Locations | Pennsylvania | — | — |
| Not listed | Many Locations | Rhode Island | — | — |
| Not listed | Many Locations | Tennessee | — | — |
| Not listed | Many Locations | Texas | — | — |
| Not listed | Many Locations | Virginia | — | — |
| Not listed | Many Locations | Washington | — | — |
| Not listed | Many Locations | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01158183, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 8, 2010 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01158183 live on ClinicalTrials.gov.